Catalyst Crew Technologies Establishes Venezuelan Subsidiary LataMed AI VE to Boost Telehealth Operations

Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, has announced the establishment of LataMed AI VE, C.A., a Venezuelan operating subsidiary designed to support its telehealth regulatory, commercialization, and healthcare deployment initiatives in Venezuela. The move marks a strategic step in the company’s expansion into emerging markets, particularly Latin America.

The subsidiary is expected to serve as a principal localized entity for the phased deployment of Catalyst Crew’s telehealth platform, healthcare delivery infrastructure, and regulatory progression efforts. Management anticipates that operational activities through LataMed AI VE, C.A. may commence in the coming weeks, subject to continued regulatory progression, operational readiness, and broader commercialization planning.

LataMed AI VE, C.A. will work alongside the company’s existing framework, including Inversiones Long 33, C.A., as part of a broader regional infrastructure strategy. This strategy aims to strengthen local regulatory flexibility, healthcare service operations, permit management, and long-term commercialization scalability. Management believes the subsidiary will significantly enhance the company’s ability to manage localized healthcare operations, support phased commercialization initiatives, improve operational deployment readiness, and facilitate broader telehealth platform expansion across Venezuela and other targeted Latin American markets.

The subsidiary is expected to support patient onboarding systems, provider coordination capabilities, telehealth infrastructure deployment, regulatory compliance procedures, commercialization planning, healthcare analytics integration, and broader operational management as part of the company’s evolving Latin American healthcare ecosystem. Catalyst Crew continues to advance telehealth platform development, pilot deployment readiness, regulatory progression, healthcare analytics integration, and broader commercialization initiatives through its digital healthcare ecosystem, including active platform development and testing at its telehealth interface at latamedai.org.

Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: “The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution.”

The company continues to coordinate regulatory initiatives with applicable healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader healthcare infrastructure and commercialization objectives.

Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets.